Veterinary Medicines

Umpimycin vet intramammaarisuspensio

Authorised
  • Framycetin sulfate
  • Benethamine penicillin
  • Penethamate hydriodide
Download as PDF

Product identification

Medicine name:
Umpimycin vet intramammaarisuspensio
Active substance:
  • Framycetin sulfate
  • Benethamine penicillin
  • Penethamate hydriodide
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Framycetin sulfate
    100.00
    milligram(s)
    /
    1.00
    Syringe
  • Benethamine penicillin
    280.00
    milligram(s)
    /
    1.00
    Syringe
  • Penethamate hydriodide
    100.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        9
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC25
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Finland
Available in:
  • Finland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lohmann Pharma Herstellung GmbH
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Finnish Medicines Agency
Authorisation number:
  • 9293
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 5/09/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 5/09/2025
Download